Study on the Effectiveness and Safety of Nizubaglustat in Patients with Niemann-Pick Type C, GM1, or GM2 Gangliosidosis
- Substances:Nizubaglustat
France- Participants:0–17 years · 18–64 years
- Substances:Nizubaglustat
Rare diseases
Investigational molecules
Locations
FranceStudy of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma
AustriaStudy of tezepelumab effects on airway barrier function in patients with severe asthma, with or without chronic rhinosinusitis with nasal polyps
AustriaStudy on the Safety and Effectiveness of Parecoxib and Sodium Chloride for Patients Hospitalized with Spontaneous Subarachnoid Hemorrhage
CzechiaStudy of Olaparib for Patients with Recurrent Ovarian Cancer Without BRCA Gene Mutations
ItalyStudy on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients
DenmarkStudy on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex
PolandStudy on Deferoxamine to Improve Hypoxia Response in Type 1 Diabetes Patients
SwedenStudy on Esketamine and Diphenhydramine for Treating Depression and Negative Symptoms in Schizophrenia Patients
AustriaStudy on ICEF15 for Treating Fecal Incontinence in Patients with Anal Sphincter Dysfunction
AustriaA Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse
GermanyStudy Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.